Skip to main content
Jamie W. Rhoads
Rating: 4.9 of 5
( out of 283 reviews )

Jamie W. Rhoads, MD

Languages spoken: English

Clinical Locations

Primary Location

Midvalley Health Center Dermatology

Dermatology
243 East 6100 South
Murray , UT 84107

Veterans Administration Medical Center

Dermatology Clinic
500 S Foothill Blvd
Salt Lake City , UT 84148
  • Dr. Jamie Rhoads is board certified in dermatology and completed a 2-year fellowship in psoriasis. She specializes in inpatient dermatology and complex medical dermatology, particularly autoimmune skin disease.

    Board Certification

    National Board of Medical Examiners

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 283 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    December 19, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Dr Rhoads is awesome hope I never have to go anywhere else!

    December 08, 2025
    MIDVALLEY
    Rating: 5 out of 5

    I have in the past, and will again.

    November 28, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Very good at her job

    November 21, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Dr Rhoads is excellent! She is very knowledgeable and kind. I feel heard and well taken care of.

    November 21, 2025
    MIDVALLEY
    Rating: 5 out of 5

    I want to have a wide range of natural treatments not drugs that cause death and illness

    November 20, 2025
    MIDVALLEY
    Rating: 5 out of 5

    She is great

    October 25, 2025
    MIDVALLEY
    Rating: 5 out of 5

    She is the best! She checks your skin so carefully. She listens to your concerns and makes you feel Comfortable and is friendly.

    October 24, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Dr. Rhodes is very good and helped me with a skin infection and issues that I had a hard time getting resolved with other doctors. She is very good and helpful with what she does. I sincerely appreciate her helping!

    October 23, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Dr. Rhoads is terrific!

  • Dr. Jamie Rhoads is board certified in dermatology and completed a 2-year fellowship in psoriasis. She specializes in inpatient dermatology and complex medical dermatology, particularly autoimmune skin disease.

    Board Certification and Academic Information

    Academic Departments Dermatology -Associate Professor (Clinical)
    Board Certification
    National Board of Medical Examiners

    Education history

    Residency Dermatology - University of Utah Resident
    Graduate Training Clinical Investigation - University of Utah M.S.C.I
    Research Fellow Dermatology - University of Utah Research Fellow
    Internship Internal Medicine - University of Florida College of Medicine-Jacksonville Intern
    Professional Medical Medicine - University of Florida College of Medicine M.D.
    Undergraduate Majors: Chemistry, Biochemistry; Minors: Biology, Math - Florida State University B.S.

    Selected Publications

    Journal Article

    1. Williams A, Curtis JA, Rhoads J, LaChapelle CR, Fleming ID, Lewis GM, Thompson CM, Madigan LM (2025). Improving identification of SJS/TEN and its mimics across a large geographic area: Outcomes from a novel telemedicine collaboration. J Am Acad Dermatol. (Read full publication)
    2. Seifert RM, Teames CR, Sahni V, Noot C, deShazo RA, Powell DL, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). The impact of allergen avoidance on oral lichen planus: A retrospective cohort-based comparison. J Am Acad Dermatol. (Read full publication)
    3. Noot CH, Hansen AM, Frost Z, Rhoads JLW, Hull CM, Zone JJ, Hopkins ZH (2025). Oral lichen planus treated with upadacitinib: A case series. JAAD Case Rep, 63, 125-127. (Read full publication)
    4. Stone CJ, Broadbent E, Sahni VN, Gray L, Clarke JT, Hansen CB, Rhoads JLW, Zone JJ, Hull CM, Wu YP, Kean J, Secrest AM, Hopkins ZH (2025). Use of the Connor-Davidson Resilience Scale in a complex medical dermatology clinic: Cross-sectional study evaluating associations between resilience, health-related quality of life, and mental health. J Am Acad Dermatol, 93(1), 252-255. (Read full publication)
    5. Eichenfield DZ, Knapp KD, Claxton A, Munoz B, Crawford JM, Balu S, Kim Y, Schneider S, Haft MA, Silverberg JI, Thaci D, Eichenfield LF, Bagel J, Rhoads JW, Paller AS, TARGET-DERM AD Investigators (2025). Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry. Dermatitis. (Read full publication)
    6. Rhoads JLW, Lavasani L, Rasouliyan L, Laouri M, Noe M (2025). Real-world clinical characteristics and treatment patterns of generalized pustular psoriasis flares. J Am Acad Dermatol. (Read full publication)
    7. Noe MH, Lavasani L, Rasouliyan L, Laouri M, Rhoads JLW (2025). Healthcare Resource Utilization Among Patients With Generalized Pustular Psoriasis: The Impact of Flares and Disease Severity. J Psoriasis Psoriatic Arthritis, 24755303251317193. (Read full publication)
    8. Sahni V, Teames C, Seifert R, Conley M, deShazo R, Powell D, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). The Association Between Skin Allergy Testing and Oral Squamous Cell Carcinoma in Oral Lichen Planus: A Retrospective Cohort Study. Arch Dermatol Res, 317(1), 207. (Read full publication)
    9. Haft MA, Knapp KD, Claxton A, Munoz B, Crawford JM, Balu S, Kim Y, Schneider S, Eichenfield DZ, Silverberg JI, Eichenfield LF, Bagel J, Rhoads JLW, Paller AS (2024). Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry. Curr Med Res Opin, 40(12), 2057-2066. (Read full publication)
    10. Rhoads JLW, Christensen L, Westerdahl S, Stevens V, Chapman WW, Conway M (2024). Automatic Extraction of Skin and Soft Tissue Infection Status from Clinical Notes. Stud Health Technol Inform, 310, 579-583. (Read full publication)
    11. Rhoads JLW, Malatestinic WN, Burge R, Ganz ML, Duffin KC (2023). Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data. J Psoriasis Psoriatic Arthritis, 9(1), 5-15. (Read full publication)
    12. Snyder AM, Taliercio VL, Rich BE, Brandenberger AU, Webber LB, Biber JE, Hess R, Rhoads JL, Secrest AM (2023). Quality of Life and Avoiding Triggers of Atopic Dermatitis Flares: A Qualitative Study. Skinmed, 21(4), 233-235. (Read full publication)
    13. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2023). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full publication)
    14. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2023). Atopic Dermatitis: A Qualitative Study on the Burdens of Living with Itchiness. J Clin Aesthet Dermatol, 16(7), 22-25. (Read full publication)
    15. Bolender CM, Jimenez A, Clarke JT, Willson TM, Stevens VW, Rhoads JLW (2022). Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans. JAMA Dermatol, 158(11), 1321-1323. (Read full publication)
    16. Snyder AM, Brandenberger AU, Taliercio VL, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2022). Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis. Int J Behav Med, 30(3), 409-415. (Read full publication)
    17. Snyder AM, Taliercio VL, Rich BE, Brandenberger AU, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JL, Secrest AM (2022). Why so Blue? (Or Should I Say Red?) Recognizing the Emotional Impact of Psoriasis on Patients and Family Members: A Qualitative Study. J Psoriasis Psoriatic Arthritis, 7(2), 60-66. (Read full publication)
    18. Snyder AM, Taliercio VL, Webber LB, Brandenberger AU, Rich BE, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The Role of Pain in the Lives of Patients with Psoriasis: A Qualitative Study on an Inadequately Addressed Symptom. J Psoriasis Psoriatic Arthritis, 7(1), 29-34. (Read full publication)
    19. Skemp-Dymond G, Lebiedz-Odrobina D, Zuromski LM, Rhoads JLW, Tebo AE (2021). Assessment of a line immunoassay for the detection of mi-2 antibodies. Am J Clin Pathol, 157, 506-509. (Read full publication)
    20. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families. JMIR Dermatol, 4(2), e29826. (Read full publication)
    21. Flint ND, Rhoads JLW, Carlisle R, Ferrel M, Hopkins ZH, Secrest AM (2021). The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone. Dermatol Online J, 27(8). (Read full publication)
    22. Beshay A, Petersen M, Rhoads JLW (2021). Severe EGFR inhibitor-induced acneiform eruption responding to dapsone. Dermatol Online J, 27(7). (Read full publication)
    23. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42–48.
    24. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42-48. (Read full publication)
    25. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of pain from atopic dermatitis: Interview and focus group study with patients and their families. JMIR Dermatol, 4(2).
    26. Rhoads JLW, Willson TM, Sutton JD, Spivak ES, Samore MH, Stevens VW (2019). Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections. Clin Infect Dis, 72(4), 675-681. (Read full publication)
    27. Walsh JA, McFadden M, Woodcock J, Clegg DO, Helliwell P, Dommasch E, Gelfand JM, Krueger GG, Duffin KC (2013). Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol, 69(6), 931-7. (Read full publication)
    28. Duffin KC, Woodcock J, Krueger GG (2010). Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association. Dermatol Ther, 23(2), 101-13. (Read full publication)

    Review

    1. Sahni VN, Yim R, Amanullah A, Sahni D, Powell D, deShazo R, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). An Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review. [Review]. Dermatitis. (Read full publication)

    Case Report

    1. Dao DP, Sahni VN, Sahni DR, Abbott J, Rhoads JLW (2021). Vasculitis with granulomatosis: An atypical presentation of giant cell arteritis. JAAD Case Rep, 16, 124-126. (Read full publication)
    2. Lo MC, Woodcock JL (2011). Case of EBV-induced adrenal insufficiency, cardiac tamponade, and pleural effusions. Fed Pract, 28(7), 23-27.

    Letter

    1. Seifert RM, Hull CM, deShazo RA, Powell DL, Rhoads JLW, Zone JJ, Hopkins ZH (2025). The Impact of Allergen Avoidance in Burning Mouth Syndrome: A Case Series. [Letter to the editor]. Dermatitis. (Read full publication)
    2. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full publication)